chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The Nurse used 2 shots on me, she said the first shot did not go all the way in, so she disposed of it and used a second dose. I dont know how much of the first dose she used, if any, the second dose was done immediately following the first done on this day.
This spontaneous prospective pregnancy report as received from a nurse practitioner refers to a 26 year old female patient with no pertinent medical history and no known drug reactions/allergies who on 05-OCT-2011 was vaccinated with her first dose of GARDASIL (Lot number 670048/0963AA; expiration date 09-NOV-2013) (route not provided). There was no concomitant medication. The nurse practitioner reported that the patient was now 5 weeks pregnant. A home pregnancy urine test was performed, on an unkonwn date, approximately in 2011. The patient sought medical attention. There was no adverse event reported. Last menstrual period was 11-OCT-2011. Estimated delivery date was 19-JUL-2012. The pregnancy outcome was unknown. The outcome of vaccine exposure during pregnancy was unknown. Follow up information was received from the receptionist on 25-FEB-2014. The patient's first visit was on 05-OCT-2011. In September 2012, the patient had an office visit and had a 2 month old daughter. Information about the patient's obstetrics and gynecology (OB-GYN) was not available. Additional information is not expected.
mom describes pt fell to floor trembled, did not respond to mom, was lethargic for the remainder of day;
FOGGY EYED IN THE LEFT EYE/WAS SEEING DOUBLE SOME DAYS; WHEN USED WRISTS A LOT OF PAIN; WHEN USED HANDS  A LOT OF PAIN; This spontaneous report received from a patient concerned a 69 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: moderate to severe rheumatoid arthritis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number was not reported) dose was not reported, administered on 01-MAR-2021 for covid-19 vaccination. Non-company suspect drugs included: upadacitinib (form of admin unknown, oral, batch number was not reported) dose, frequency, and therapy dates were not reported for moderate to severe rheumatoid arthritis. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced foggy eyed in the left eye/was seeing double some days, when used wrists a lot of pain, and when used hands a lot of pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable; and action taken with upadacitinib was not reported. The patient had not recovered from when used hands a lot of pain, and when used wrists a lot of pain, and the outcome of foggy eyed in the left eye/was seeing double some days was not reported. This report was non-serious.
The patient received the COVID 19 vaccine first dose on 4/10/2021 the vaccine administered was Moderna. The second dose was administered on 05/10/2021 and the vaccine administered was Pfizer.
warmth and erythema 4x5 cm around area of vaccination from 2 days ago. We drew a borderline around rash with sharpie marker. Rec. ice application. F/U if fever or increased redness out of boundary of marker.
About 20 minutes after vaccine, the right side of my face (including nose, some of my tongue) felt numb or tingly.   Very mild.   Symptoms disappeared within, say, a half hour and did not return.  The following morning I had fleeting head aches on right side - each lasting a' second or so only, and several hours apart.   By the afternoon they disappeared.  I am having no other symptoms.   My arm never hurt at the injection site.   I'm not even  concerned but feel I should mention this reaction because I will be getting a second shot on March 16.  Is it safe?  Again, I have no symptoms any longer and feel great.
Information has been received from a certified medical assistant referring to a patient of unknown age and gender. The patients' medical history, concurrent conditions, concomitant medications were not reported. On 13-APR-2015, the patient was vaccinated with a dose of improperly stored PROQUAD (Merck) (dose, route of administration, lot number were not reported). No adverse event were reported. This is one of several cases reported by the same source. Additional information has been requested.
Patient came into pharmacy complaining about arms shaking 1 to 1 1/2 hours after vaccination. Notified me on 12/7/11.
lt arm swelling, redness, warmth up to elbow 2 1/2 days p/vax;tx w/oral ATB;'
Patient recieved age 12 and up Pfizer covid vaccine rather then Pfizer covid vaccine Age 5- 11 years of age. While observing patent after adminisatrtion. Patient was feeling fine and no reaction had occured.
This spontaneous report was received from a pharmacist concerning a 67 year old healthy patient of unknown gender with no pertinent medical history. On 11-DEC-2012, the patient was vaccinated with a first dose of GARDASIL (lot number and expiry date were reported as H015863 and 24-FEB-2015 respectively) that was exposed to 74 degree Fahrenheit (reported as 74F) for 5 days (dose, route unspecified) by the registered nurse. No concomitant medications were reported. No adverse effect was observed or reported. Additional information has been requested.
I had the headache, tiredness, sore upper arm for a couple days then was fine.  Around April 3,4,5,6th I had major arthritic-type pain in my right hand/joints. And then Friday the 9th, I noticed where the injection site was, was red, warm, with a red ring around it. I went to the doctor this morning (the 10th) and he thinks it is cellulitis caused by the vaccine and prescribed my 2 antibiotics
indicate at which point in the process the medication error occurred; No additional AE/PQC reported.; administered an expired dose of MMRII; This spontaneous report was received from a medical assistant and vaccine provider referring to a 4-year-old male patient. Concomitant vaccinees included diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (DTAP), polio vaccine inact (IPV) and varicella zoster vaccine (VARICELLA VACCINE).  On 16-MAY-2022, the patient was vaccinated with an expired dose of the second dose (previous doses reported as 1) of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (lot # T016352, expiration date 12-MAY-2022, anatomical location: left thigh; strength and dose were not reported) subcutaneously for prophylaxis (expired product administered). The measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) was reconstituted with not expired and no temperature excursion stored sterile diluent (lot# S037029, expiration date: 30-AUG-2022). The patient had no illness at time of vaccination. The medication error occurred in the process of preparation for administration. It was not occurred as a result of reading from digital data logger. No additional adverse event (AE) or product quality complaint (PQC) was reported.
Rash on the abdomen; Headache; Sore neck; extreme tiredness; fever; Sore arm; A SPONTANEOUS REPORT from was received concerning a 75 Years old, Female patient who received Moderna's COVID-19 shot  on 11FEB and only had a slight, sore arm. No medication needed. On the 19th she had what seems to be a reaction with headache, sore neck, extreme tiredness and a fever of 100F.  She called back again on 22feb2021  she I woke up feeling fine and her fever was in 98F. But then last night she developed a rash on my abdomen. Ishe already completed that V-safe form. Agent confirmed the patient did not consume or apply any treatment medication, and collected thyroid medication and Lipitor as concomitant drugs. When the agent asked for a primary doctor's contact, the caller mentioned she has recently transferred into a new state and didn't have a new primary doctor yet  Treatment outcome is unknown
Patient with no medical history, received dose of Jannsen and within 16min of the vaccination started having tingling to Left arm down to hand.  No rash noted and experienced no other symptoms.
Information has been received from a registered nurse concerning a patient who on 21-SEP-2000 was vaccinated with a dose of Varivax. Subsequently, on 21-MAR-2006, the patient developed breakthrough varicella. Unspecified medical attention was sought. There was no product quality complaint. No additional information is expected.
Reports recent COVID booster (moderna--yesterday)Patient has had back pain since this morning, pain in neck and bilat flank/back affecting her abilities to do usual routines. Denies pain with urination.   ABC are intact. Febrile.   Patient nares swabbed.          HPI: Patient is a 39 y.o. female who presents to the ED with the complaint of body aches, flank pain and fever. Symptoms start today. She received the moderna booster vaccine yesterday afternoon. No dysuria or vomiting.   Review of Systems  Constitutional: Positive for fever and malaise/fatigue. Negative for chills.  Respiratory: Negative.  Negative for cough.   Cardiovascular: Negative.  Negative for chest pain.  Gastrointestinal: Negative for abdominal pain and vomiting.  Genitourinary: Positive for flank pain. Negative for dysuria and urgency.  Musculoskeletal: Positive for myalgias.  Skin: Negative for rash.  Neurological: Negative.  Negative for dizziness and seizures.
Phone call from pt today c/o burning sensation right deltoid with vaccine administration 5/3/06. 4 days after (5/7/06) developed a tingling sensation right arm. Use anti inflammatory such as Advil, heat to area, if no improvement to see MD in 3 days.
Patient notes 6 days after receiving 3rd dose of Moderna "booster", patient developed full body urticaria without angioedema. Improved with oral antihistamines.
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 71-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 21Jan2021 at 09:00 as dose number unknown, single (Batch/Lot number: unknown) at the age of 70 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Nutopenia" (unspecified if ongoing); "Connective tissue disorder" (unspecified if ongoing); "hypothyroidism" (unspecified if ongoing); "Known allergies: Shellfish" (unspecified if ongoing); "Known allergies: Sulfa" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Codeine, reaction(s): "Known allergies: Codeine"; Gluten, reaction(s): "Known allergies: Gluten". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical information: There was no other medication in 2weeks. Anti-viral product details: COVID 19 Treatment included Paxlovid treatment start date: 17Jul2022 and treatment stop date: 21Jul2022.known allergies were Gluten, Sulfa, Codeine, Shellfish and other medical history included Neutropenia, Connective tissue disorder, hypothyroidism. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Redness and swelling at injection site immediately after receiving vaccination. Small pencil eraser size when given, increased slightly in 5-10 minutes.
This spontaneous report as received from a Licensed Practical Nurse refers to a patient of unknown age. On 30-JAN-2014 the patient was vaccinated with an expired dose of M-M-R II (lot# 0232AE, exp date 26-JAN-2014, dose, route and indication not reported). The product did not have any previous temperature excursions. No adverse symptoms reported. Additional information has been requested.
ACHY; SUPER TIRED; STUBBORN THROBBING HEADACHE; MILD FEVER; This spontaneous report received from a patient via a company representative concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. The batch number was not reported. The company is unable to perform follow up to obtain batch/lot numbers. On an unspecified date, the subject experienced achy, super tired, stubborn throbbing headache, and mild fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from achy, super tired, stubborn throbbing headache, and mild fever. This report was non-serious.
Approximately 4 hours after vaccine, noted hives/welts on arms, took cetirizine. Went to bed. ~8pm (4 hours later) was very itchy, swollen, discolored face, face felt cold/body hot. No difficulty breathing.  Lips purplish, arms swollen.  Went to ED.  Given benadryl, 2 other pills, watched for 30 minutes.   No epinephrine.  Hives improved, released,  had headache.  Next day improved, but still mild headache and groggy.  Hives gone completely 48 hours. Mild headache persists.  No prior experience like this.
3yr.4month h/m received flu vaccine prior in 01/06/06 and 12/02/05, pt given flu vaccine at 4:30pm and at 4:40pm upon discharge mother noticed child scratching and itching mother brought child back to the nurse and child presented with rash to forhead and a few spots of itching to upper back.  No respiratory symptoms, no whezzing, and no SOB noted. Child alert, pediatrician at the clinic examined the patient and 911 was called for child to go to ER for close observation.  Mother informed Dr. child had eaten eggs and sausage in the morning.  Ambulance came and child left on stable conmdition to go to Hospital.
Patient stated that vaccine was administers below the deltoid muscle (~5 inches before shoulder bone). She experienced redness, swelling, and a tingling sensation in the area of administration. About a week later, all these symptoms are subsiding.
Fever of 102.8 (A), pain, lethargy, diarrhea.
Felt increasingly weak; chills; headache; cough; runny nose; body ached so bad; had no taste for anything; CONGETSTED; RUNNY NOSE; constipated; Fever progressed; nauseous; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), RHINORRHOEA (runny nose), NASAL CONGESTION (CONGETSTED), CONSTIPATION (constipated) and PYREXIA (Fever progressed) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L204) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Flu.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced COUGH (cough), RHINORRHOEA (runny nose), NASAL CONGESTION (CONGETSTED), CONSTIPATION (constipated), PYREXIA (Fever progressed), CHILLS (chills) and HEADACHE (headache). On 16-Jan-2021, the patient experienced ASTHENIA (Felt increasingly weak). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 16-Jan-2021, COUGH (cough), NASAL CONGESTION (CONGETSTED), CONSTIPATION (constipated), PYREXIA (Fever progressed), ASTHENIA (Felt increasingly weak) and CHILLS (chills) had resolved. On 17-Jan-2021, HEADACHE (headache) had resolved. At the time of the report, RHINORRHOEA (runny nose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, Body temperature: 99f (normal) 99F. On 16-Jan-2021, Body temperature (Unknown-high): 104°f (High) 104°F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
1-3 days after vaccination: Fever, malaise, lightheadedness, chills, and arm pain. Also slightly winded  5-7 days after vaccination: Fever returns ~99.2, axillary lymphadenopathy and pain, and malaise
This spontaneous report received from a patient via a company representative concerned a patient of unspecified age, sex, race, and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient was previously treated with covid-19 vaccine (dose number in series: 1) (suspension for injection, route of admin not reported, batch number: unknown and expiry: unknown), dose was not reported, administered 1 in total on APR-2021 for prophylactic vaccination. The patient did not experience any pain following covid-19 vaccine (dose number in series: 1). The patient received covid-19 vaccine (dose number in series: 2) (suspension for injection, route of admin not reported, batch number: unknown and expiry: unknown) dose was not reported, 1 total, administered on 04-JAN-2022 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 04-JAN-2022, following vaccination with covid-19 vaccine, the patient experienced quite a bit of discomfort which had nothing to do with the way the vaccine was administered (dose number in series: 2). The action taken with covid-19 vaccine was not applicable. The outcome of discomfort was unknown. This report was non-serious.
tongue felt numb, denied shortness of breath. Benadryl 25mg given po, no rash, patient left after 20 minute observation after Benadryl given.
Pt stated his arm was painful, red and hot starting the day after vaccination and Dr. confirmed cellulitis.
This spontaneous report was received from a consumer (patient's wife who was enrolled in Market Research Program) referring to a male patient of unknown age. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with PNEUMOVAX 23 (lot, batch# number and route of administration was not reported) for prophylaxis. On an unknown date, 3 days after vaccination the patient experienced pneumonia and was hospitalized. The outcome of pneumonia was unknown. Causality assessment was not reported. Upon internal review, pneumonia was determined to be medically significant.
Elevated temp (101), naseua, chills, headache for over 24 hours.
Diagnosed with A Fib on May 10, 2021.   No symptoms, no previous history of A Fib.  Not sure if it is related to covid vaccine (pfizer) or coincident?
Pt recv vax on 3/24/99; on 3/26/99 pt exp muscle pain of upper body
Complete immobility due to severe pain in joints and muscles - could not leave bed for 2 days except to toilet - was told the severity of my pain & immobility was to be expected- but not reported in advance - not just flu muscle aches - no fever or other symptoms except severe debilitating pain - could not work for 2 days - reduced pain - still in excess of fibromyalgia pain I have become used to - continued to 2nd dose - told to get it anyway
Erythema multiform. Swelling of arm: Erythema. Treatment drugs used: DIPHENHYDRAMINE dose: 25 units: MG freq: TID Route: PO, METHYLPREDNISOLONE Dose: Units: Freq: Route.
Throat tightening, visible rash, difficulty breathing, changes in phonation,  hypotension approximately 10 minutes after receiving vaccination.  Given Epi 0.3mg IM X 2 doses, PO Benadryl and transported via ambulance to ED.  Left facility with stable vital signs and improvement of symptoms.
12/26/2021, contracted COVID. I started feeling a scratchy throat for three days, right after I was having cough and extreme headache. I had several test PCR and Rapid that come back as negative. I took a second PCR test and that came back as positive on 12/29/2021 at 02:06 AM. I was having trouble staying awake, after 3 hours I would feel my body shut down. It was very hard for me to stay awake. I had a cough that was severe in the beginning but it got better. After this 3rd dose of the vaccine, I am having backaches everyday, and extreme hair loss. I have a lingering cough, it has been 4 months now.
8 days after varivax 4 little welts at site of injection and swelling and warmth a day later.
Second dose of Moderna vaccine given in less than 21 days; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose of Moderna vaccine given in less than 21 days) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002C21A and 023C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose of Moderna vaccine given in less than 21 days). On 14-May-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose of Moderna vaccine given in less than 21 days) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  No treatment medication was reported.
Left deltoid redness swelling since 1/8/10 getting better. Swelling & redness going down. Instructed dad to place ice pack & MOTRIN for pain. Verified with RN.
12/19 vaccination 12/20 10pm As soon as I lied down, room spinning. Went to sleep. Midnight on 12/21; woke up 'not feeling well'; weakness, faint, shaky. You contacted your brother and proceeded to the ER.  2am started to feel better 3:30 am dishcarged home. Wope up at 6:30 am. Chills, achy. Went to work; felt chilled all Monday into the evening until eventually subsided.  **2 negative COVID in Nov **Flonase for allergies  **2nd Pfizer vaccination on 1/9/2020. Milder symptoms for couple of days, into Tuesday. 1/12/2021; mild chills, mild body aches.
11:00 AM Erythema and swelling present to injection site on left thigh in clinic. 1300 called pt's mother and she reported redness and swelling resolved.
Patient got light headed and passed out sitting in his chair. His pupils were very dilated and he fell in and out of consciousness for about 2 minutes. EMTs arrived and cleared him to go home.
OCT 9TH BRIGHT FLASHES OF LIGHTS IN RIGHT EYE, FOLLOWED BY DOUBLE VISION, OCT 11 PT SEEN BY DR. CT SCAN & EXAM DONE. OCT 16TH PT SEEN BY DR. EYE SPECAILIST, BLOOD TEST & EXAM DONE, DX WITH RIGHT EYE 6TH NERVE PALSEY, (STROKE IN EYE). PT SEEN OCT 20 BLOOD TEST DONE & EXAM. PT CONTINUES TO HAVE DOUBLE VISION, OCT 30 PT SEEN BY DR. DOUBLE VISION CONTINUES BUT IS IMPROVING. ALL INFORMATION REPORTED TO ME BY PT.
After one and a half weeks, my right upper arm, at the injection site, has a red patch that itches and is warm. It is still red and itchy and warm.
having little confusion since the vaccine shot; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (BNT162B2) at single dose on an unspecified date for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced having little confusion since he/she got the vaccine shot on an unspecified date. The outcome of event was unknown.  Amendment (PSSR): This follow-up report is being submitted to allow appropriate reporting to health authorities.  Follow-up attempts have been completed and no further information is expected. The batch/lot number is not available despite the follow-up attempts made.
Per the clinical lead Hepatitis B and HPV vaccine trasported to clinic in portable cooler. A vaccine excursion occurred with the portable cooler. The temperature on the portable cooler went out of range based on Engerix- B and Gardasil manufacturer recommendations. The portable cooler reconditioned and Hepatitis B and HPV vaccine admistered to patient. Manufacturer conatcted by representative. Per the Health Department they were advised by GlaxoSmithKline and Merck that the Hepatitis B and Gardsil vaccine was not viable and the patient needed to be revaccinated.